Alpha Tau Medical Future Growth
Future criteria checks 2/6
Alpha Tau Medical is forecast to grow revenue at 52.5% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 16.5% |
| Revenue growth rate | 52.5% |
| Future return on equity | -5.4% |
| Analyst coverage | Low |
| Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?
May 25
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans
Nov 08Alpha Tau director gives up board seat to take up chief commercial officer role
Sep 02Alpha Tau Medical GAAP EPS of -$0.03
Aug 25Alpha Tau: Treating Cancer With Precision Alpha Radiation
Apr 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 34 | N/A | N/A | N/A | 2 |
| 12/31/2026 | 19 | N/A | N/A | N/A | 3 |
| 12/31/2025 | 1 | N/A | N/A | N/A | 4 |
| 12/31/2024 | N/A | N/A | N/A | N/A | 4 |
| 9/30/2024 | N/A | -30 | N/A | N/A | N/A |
| 6/30/2024 | N/A | -28 | -27 | -21 | N/A |
| 3/31/2024 | N/A | -29 | N/A | N/A | N/A |
| 12/31/2023 | N/A | -29 | -24 | -18 | N/A |
| 9/30/2023 | N/A | -25 | N/A | N/A | N/A |
| 6/30/2023 | N/A | -23 | -19 | -18 | N/A |
| 3/31/2023 | N/A | -16 | N/A | N/A | N/A |
| 12/31/2022 | N/A | -34 | -25 | -24 | N/A |
| 9/30/2022 | N/A | -34 | N/A | N/A | N/A |
| 6/30/2022 | N/A | -36 | -24 | -22 | N/A |
| 3/31/2022 | N/A | -41 | -18 | -15 | N/A |
| 12/31/2021 | N/A | -27 | -15 | -12 | N/A |
| 9/30/2021 | N/A | -26 | N/A | N/A | N/A |
| 6/30/2021 | N/A | -24 | -13 | -9 | N/A |
| 3/31/2021 | N/A | -19 | -12 | -9 | N/A |
| 12/31/2020 | N/A | -9 | -11 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DRTS's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if DRTS's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if DRTS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: DRTS's revenue (52.5% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: DRTS's revenue (52.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DRTS is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 16:20 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alpha Tau Medical Ltd. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristen Kluska | Cantor Fitzgerald & Co. |
| Yigal Nochomovitz | Citigroup Inc |
| Neena Bitritto-Garg | Citigroup Inc |